Bharat Rasayan Q2 PAT slips 13% YoY to Rs 23 cr

  • capital market |
  • 16 Nov, 2022 |
  • 11:53 AM
Profit before tax skid 13.5% year on year to Rs 31.06 crore in the quarter ended 30 September 2022. Total expenses rose 12.03% to Rs 263.88 crore in Q2 FY23 from Rs 235.55 crore in Q2 FY22. Cost of raw materials consumed surged 34.8% YoY to Rs 247.75 crore while employee benefits expense declined 1.3% YoY to Rs 19.89 crore during the period under review. On the margins front, operating profit margin declined to 11.40% in Q2 FY23 from 13.65% in Q2 FY22. Net profit margin slipped to 8.07% in Q2 FY23 as compared to 9.88% in Q2 FY22. As on 30 September 2022, the companys net worth stood at Rs 829.91 crore and its debt to equity ratio was 0.14 times. Bharat Rasayan serves a wide range of industries including but not limited to pharmaceuticals, bulk drugs, R&D, petrochemicals, flavors & fragrances and specialty chemicals. The scrip declined 0.96% to currently trade at Rs 10,365.70 on the BSE. Powered by Capital Market - Live News

Invest wise with Expert advice

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
ad IconAd Image

Most Read News

Article Image
  • 14 March, 2022 |
  • 7:03 AM

The US Federal committee's meeting will conclude on March 16, 2022.

Most Shared News

No Record Found